Non categorizzato Pfizer and BioNTech start mid-faze trial for Omicron vaccine Luglio 27, 2022 0 commenti American Pfizer Inc. and its German partner BioNTech SE announced on Wednesday that they initiated a “randomized, active-controlled, observer-blind” mid-stage vaccine trial for an unspecified Omicron … About the author:
Get involved!
Comments